IL-15 transduced TGFBR2 KO CAR.TROP2-engineered cord blood-derived NK cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IL-15 transduced TGFBR2 KO CAR.TROP2-engineered cord blood-derived NK cells, covering 2026-04-16 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK) [Phase 1]